Salsalate
- Generic Name
- Salsalate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C14H10O5
- CAS Number
- 552-94-3
- Unique Ingredient Identifier
- V9MO595C9I
- Background
Salsalate is a nonsteroidal anti-inflammatory agent for oral administration. Salsalate's mode of action as an anti-inflammatory and antirheumatic agent may be due to inhibition of synthesis and release of prostaglandins. The usefulness of salicylic acid, the active in vivo product of salsalate, in the treatment of arthritic disorders has been established. In...
- Indication
For relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorders.
- Associated Conditions
- -
- Associated Therapies
- -
Effect of Salsalate on Bed Rest-Induced Vascular Dysfunction
- First Posted Date
- 2007-11-06
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Boston University
- Target Recruit Count
- 60
- Registration Number
- NCT00553995
- Locations
- 🇺🇸
Boston University School of Medicine, Boston, Massachusetts, United States
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
- First Posted Date
- 2006-10-26
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Joslin Diabetes Center
- Target Recruit Count
- 277
- Registration Number
- NCT00392678
- Locations
- 🇺🇸
Endocrine Clinical Research, Winter Park, Florida, United States
🇺🇸Kaiser Permanente, Atlanta, Georgia, United States
🇺🇸Emory School of Medicine, Atlanta, Georgia, United States
The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy Volunteers
- First Posted Date
- 2006-06-21
- Last Posted Date
- 2013-03-06
- Target Recruit Count
- 54
- Registration Number
- NCT00339833
- Locations
- 🇺🇸
NIDDK, Phoenix, Phoenix, Arizona, United States
Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
- Conditions
- Interventions
- First Posted Date
- 2006-05-29
- Last Posted Date
- 2020-01-21
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 71
- Registration Number
- NCT00330733
- Locations
- 🇺🇸
Carl T. Hayden VA Medical Center, Phoenix, Arizona, United States
The Study of Inflammation on Blood Glucose Levels in Obese People
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2018-02-15
- Lead Sponsor
- Joslin Diabetes Center
- Target Recruit Count
- 20
- Registration Number
- NCT00258115
- Locations
- 🇺🇸
Joslin Diabetes Center, Boston, Massachusetts, United States
Effect of Salicylate on Glucose Metabolism in Insulin Resistance States
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2019-04-30
- Lead Sponsor
- Joslin Diabetes Center
- Target Recruit Count
- 17
- Registration Number
- NCT00258128
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.